Tofflon Science and Technology Group Co., Ltd. operates as a pharmaceutical equipment supplier for the pharma and biotech industries worldwide. It operates through four segments: Biotechnology, Preparation Equipment, Engineering, and Food Engineering. The company offers technological research, such as cell technology, complex preparation, injection, and OSD laboratory; instruments, including cell therapy and nucleic acid drugs instruments, and table reactor; cryopreservation system for seeds and biological samples, and freeze-thaw system of biological stock solution; and single use technology, such as bioreactor, liquid distribution system, sterile bag, process chromatography, membrane filtration system, and others. It also provides culture medium, such as cell and gene therapy, biomacromolecule drugs, and tobitec feeding medium and other series; bioreactor and fermentation systems, including cell factory, perfusion, and complementary systems; preparation systems, such as bio-process vessel and piping, common solutions, and complex injectable formulation systems; and separation and purification systems, including disc centrifuge membrane filtration, chromatography, alkali lysis, slurry tank, and filters. In addition, the company offers freeze-drying system, including laboratory, production, and special application freeze-drying products, as well as loading and unloading system; and packaging systems, such as packaging solutions, cartoner machine, top-load cartoner machines, bilster machine, solid bottling equipment, labelling machine, and case packer with palletizer machines. Further, it provides resins, API, isolator system, cleaning and sterilization, filling line, inspection system, and engineering services. The company was formerly known as Shanghai Tofflon Science and Technology Co., Ltd. Tofflon Science and Technology Group Co., Ltd. was founded in 1993 and is based in Shanghai, China.
Metrics to compare | 300171 | Sector Sector - Average of metrics from a broad group of related Industrials sector companies | Relationship Relationship300171PeersSector | |
---|---|---|---|---|
P/E Ratio | 69.2x | 24.3x | −0.5x | |
PEG Ratio | −1.07 | 0.57 | 0.00 | |
Price/Book | 1.3x | 2.1x | 2.6x | |
Price / LTM Sales | 2.1x | 7.3x | 3.2x | |
Upside (Analyst Target) | - | 27.9% | 42.7% | |
Fair Value Upside | Unlock | 18.9% | 5.8% | Unlock |